Crawford F - Search Results

1

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.

Lawlor B, Segurado R, Kennelly S, Olde Rikkert MGM, Howard R, Pasquier F, Börjesson-Hanson A, Tsolaki M, Lucca U, Molloy DW, Coen R, Riepe MW, Kálmán J, Kenny RA, Cregg F, O'Dwyer S, Walsh C, Adams J, Banzi R, Breuilh L, Daly L, Hendrix S, Aisen P, Gaynor S, Sheikhi A, Taekema DG, Verhey FR, Nemni R, Nobili F, Franceschi M, Frisoni G, Zanetti O, Konsta A, Anastasios O, Nenopoulou S, Tsolaki-Tagaraki F, Pakaski M, Dereeper O, de la Sayette V, Sénéchal O, Lavenu I, Devendeville A, Calais G, Crawford F, Mullan M; NILVAD Study Group. Lawlor B, et al. Among authors: crawford f. PLoS Med. 2018 Sep 24;15(9):e1002660. doi: 10.1371/journal.pmed.1002660. eCollection 2018 Sep. PLoS Med. 2018. PMID: 30248105 Free PMC article. Clinical Trial.

2

Sequencing of exons 16 and 17 of the beta-amyloid precursor protein gene in 14 families with early onset Alzheimer's disease fails to reveal mutations in the beta-amyloid sequence.

Crawford F, Hardy J, Mullan M, Goate A, Hughes D, Fidani L, Roques P, Rossor M, Chartier-Harlin MC. Crawford F, et al. Neurosci Lett. 1991 Nov 25;133(1):1-2. doi: 10.1016/0304-3940(91)90042-r. Neurosci Lett. 1991. PMID: 1791986

3

Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative.

Bennett C, Crawford F, Osborne A, Diaz P, Hoyne J, Lopez R, Roques P, Duara R, Rossor M, Mullan M. Bennett C, et al. Among authors: crawford f. Am J Med Genet. 1995 Feb 27;60(1):1-6. doi: 10.1002/ajmg.1320600102. Am J Med Genet. 1995. PMID: 7485228

4

Genetic and molecular advances in Alzheimer's disease.

Mullan M, Crawford F. Mullan M, et al. Among authors: crawford f. Trends Neurosci. 1993 Oct;16(10):398-403. doi: 10.1016/0166-2236(93)90007-9. Trends Neurosci. 1993. PMID: 7504354 Review.

5

The molecular genetics of Alzheimer's disease.

Mullan M, Crawford F. Mullan M, et al. Among authors: crawford f. Mol Neurobiol. 1994 Aug-Dec;9(1-3):15-22. doi: 10.1007/BF02816100. Mol Neurobiol. 1994. PMID: 7888092 Review.

6

Technical feasibility of genetic testing for Alzheimer's disease.

Mullan M, Crawford F, Buchanan J. Mullan M, et al. Among authors: crawford f. Alzheimer Dis Assoc Disord. 1994;8(2):102-15. doi: 10.1097/00002093-199408020-00007. Alzheimer Dis Assoc Disord. 1994. PMID: 8060603 Review.

7

Age of onset in familial early onset Alzheimer's disease correlates with genetic aetiology.

Mullan M, Houlden H, Crawford F, Kennedy A, Rogues P, Rossor M. Mullan M, et al. Among authors: crawford f. Am J Med Genet. 1993 Oct 15;48(3):129-30. doi: 10.1002/ajmg.1320480303. Am J Med Genet. 1993. PMID: 8291565

8

Screening for the APP codon 670/671 mutations in Alzheimer's disease.

Houlden H, Crawford F, Rossor M, Mullan M. Houlden H, et al. Among authors: crawford f. Neurosci Lett. 1993 May 14;154(1-2):161-2. doi: 10.1016/0304-3940(93)90196-r. Neurosci Lett. 1993. PMID: 8395665

9

Association of apolipoprotein E but not B with Alzheimer's disease.

Poduslo SE, Riggs D, Schwankhaus J, Osborne A, Crawford F, Mullan M. Poduslo SE, et al. Among authors: crawford f. Hum Genet. 1995 Nov;96(5):597-600. doi: 10.1007/BF00197418. Hum Genet. 1995. PMID: 8530010

10

No interaction between the APOE and the alpha-1-antichymotrypsin genes on risk for Alzheimer's disease.

Fallin D, Reading S, Schinka J, Hoyne J, Scibelli P, Gold M, Crawford F, Mullan M. Fallin D, et al. Among authors: crawford f. Am J Med Genet. 1997 Apr 18;74(2):192-4. doi: 10.1002/(sici)1096-8628(19970418)74:2<192::aid-ajmg15>3.0.co;2-d. Am J Med Genet. 1997. PMID: 9129722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

741 results

Search Page